A web-blog (formerly known as Stu's Views and MS News), now published by MS Views and News, a patient advocacy organization. The information on this blog helps to Empower those affected by Multiple Sclerosis globally, with education, information, news and community resources.
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Wednesday, January 13, 2016
CME presentation: "So Many Options, So Little Time: Clinical Considerations to Assess MS Therapies"
Dear MS-Leaders Registrant,
Can you correctly answer this
Which of the following
statements with respect to MS treatment is CORRECT?
remyelinating therapies have not yet begun investigation in MS
5% of patients experience new or increased depression within 6 months of
initiating interferon beta-1b therapy
is rapidly eliminated from the hepatobiliary circulation
mediated teratogenicity is a concern with teriflunomide
in our Clinical Dialogue and eCase Challenge to learn the
answer to this and other questions related to MS therapy.
Up to 1.0 Free CME or CNE Credit!
Postgraduate Institute for
Medicine and Medical Logix, LLC, are currently
offering this educational program certified for CME and CNE
credit, at no charge to participants:
valid for credit through February 6, 2016
an independent educational grant from EMD Serono.
This activity is intended for
physicians, advanced practice nurses, physician assistants, registered
nurses, and other allied healthcare professionals involved in the diagnosis
and treatment of multiple sclerosis.
ACCME - This activity has
been planned and implemented in accordance with the accreditation
requirements and policies of the Accreditation Council for Continuing Medical
Education (ACCME) through the joint providership of Postgraduate Institute
for Medicine and Medical Logix, LLC. Postgraduate Institute for Medicine is
accredited by the ACCME to provide continuing medical education for
ANCC - Postgraduate Institute
for Medicine is accredited as a provider of continuing nursing education by
the American Nurses Credentialing Center's Commission on Accreditation.
ACCME - The Postgraduate
Institute for Medicine designates these enduring materials for a maximum of
1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
ANCC - This educational
activity for 0.5 contact hours is provided by Postgraduate Institute for
Medicine (per web activity). Pharmacotherapy contact hours for Advance
Practice Registered Nurses will be designated on your certificate.
Format and Method of
There are no fees for
participating and receiving CME or CNE credit for this activity. During the
accreditation period, participants must read the learning objectives and
faculty disclosures and review this internet-based activity. To take the
post-test, please click on the post-test button below the slide window of
the player. Complete the post-test and evaluation and attest to the amount
of time spent in the activity. Upon receiving a score of 70% or above,
print your CME or CE certificate.
For CME or CNE questions,
please contact Postgraduate Institute for Medicine at: firstname.lastname@example.org or (303)
Please keep in mind that you
will need to login with your email address and password to access this
program. If you forgot your password, click on the 'Forgot Password'
link in the top right corner of the site.
We hope you enjoy these
informative educational programs!
The MS-Leaders Team
Produced in cooperation with:
Medical Logix, LLC
MS Views and News helps to provide educational information for persons affected by MS
Keep current with Multiple Sclerosis news and information
by opting-in to our website: click here - thank you